Siliphos Silybin Phytosome Milk Thistle Extract
Also known as: Silybin, Silibinin, Milk thistle extract, Silymarin, Silybin phytosome, Siliphos
Overview
Silybin, also known as silibinin, is the major active flavonolignan component extracted from milk thistle (*Silybum marianum*) seeds. Siliphos® is a proprietary phytosome formulation of silybin complexed with phosphatidylcholine, designed to significantly enhance its bioavailability. Primarily used to support liver health, it is investigated for its antioxidant, anti-inflammatory, and antifibrotic properties. Silybin's native form has poor water solubility and low oral bioavailability. The phytosome complex improves absorption, reportedly increasing bioavailability by 4.6 to 9.6 times compared to non-complexed silymarin or silybin extracts. Research includes randomized controlled trials (RCTs), pharmacokinetic studies, and systematic reviews, showing promising but not definitively established clinical efficacy in chronic liver disease.
Benefits
Silybin, particularly in the Siliphos phytosome formulation, offers several evidence-based benefits. It improves liver function markers in patients with chronic liver disease and exhibits antioxidant and anti-inflammatory effects. Pharmacokinetic studies demonstrate that Siliphos enhances silybin bioavailability by 4.6 to 9.6-fold compared to conventional silymarin. This enhanced bioavailability may lead to improved clinical outcomes. Secondary benefits include antifibrotic effects in liver tissue and metabolic modulation, potentially improving insulin resistance. It is particularly beneficial for individuals with chronic liver diseases like cirrhosis and hepatitis, those exposed to hepatotoxins, or those with non-alcoholic fatty liver disease (NAFLD).
How it works
Silybin exerts its effects through multiple biological pathways. It acts as an antioxidant by scavenging free radicals and enhancing cellular antioxidant defenses. It also exhibits anti-inflammatory properties by inhibiting NF-κB and other pro-inflammatory pathways. Furthermore, silybin demonstrates antifibrotic effects by modulating hepatic stellate cell activation and collagen deposition. Primarily targeting the liver, it protects hepatocytes from toxins and oxidative stress. The Siliphos complex enhances membrane permeability and absorption, resulting in significantly higher plasma levels compared to native silybin, which has poor oral bioavailability due to low solubility and extensive first-pass metabolism.
Side effects
Silybin is generally well-tolerated with a good safety profile at doses up to 10 g/day. Common side effects, occurring in more than 5% of users, include mild gastrointestinal symptoms such as nausea and diarrhea. Uncommon side effects, affecting 1-5% of individuals, may include allergic reactions in sensitive individuals. Rare side effects, occurring in less than 1% of users, may involve hypersensitivity reactions. No significant drug interactions have been reported. Contraindications include known allergy to milk thistle or related compounds. Pharmacokinetics are not significantly altered in patients with liver cirrhosis, supporting its use in this population.
Dosage
Clinical studies often use 120 mg of silybin phytosome three times daily. The optimal dosage range is typically 120–140 mg silybin phytosome per dose, taken 2–3 times daily. Up to 10 g/day of silybin has been reported safe in studies, although typical doses are much lower. It is usually taken with meals to enhance absorption, as fatty meals may improve absorption due to the lipophilic nature of the complex. Phytosome formulations, such as Siliphos, are preferred for superior bioavailability. No specific cofactors are required.
FAQs
Is Siliphos more effective than regular milk thistle extract?
Yes, Siliphos (silybin-phosphatidylcholine complex) has been shown to have 4.6 to 9.6 times higher bioavailability compared to conventional silymarin or silybin extracts.
Is it safe to take with other medications?
No significant drug interactions have been reported, making it generally safe to use alongside other medications. However, consult with a healthcare provider before combining supplements and medications.
How soon can benefits be expected?
Pharmacokinetic improvements are immediate, but clinical benefits on liver health may take weeks to months of consistent supplementation.
Can it be used in liver disease?
Yes, it is commonly used and studied in chronic liver disease, with promising but not yet definitive clinical efficacy. Consult with a healthcare provider for personalized advice.
Research Sources
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3098397/ – This review article analyzes in vitro, in vivo, and clinical studies on silybin and liver disease. It finds that silybin phytosome has higher bioavailability than silymarin, liver cirrhosis does not alter silybin pharmacokinetics, and silybin shows antifibrotic, antioxidant, and metabolic effects, suggesting promising but not definitive clinical efficacy.
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6330464/ – This prospective, balanced, blind, single-dose, two-way crossover pharmacokinetic study with 23 healthy volunteers found that silybin-phosphatidylcholine complex (Siliphos) showed 9.6 times higher bioavailability than conventional silymarin. This represents the highest bioavailability reported to date for silybin formulations.
- https://www.sciencedirect.com/topics/medicine-and-dentistry/silibinin-phosphatidylcholine-complex – This ScienceDirect topic page provides an overview of the silibinin-phosphatidylcholine complex, highlighting its enhanced bioavailability and potential therapeutic applications. It discusses the improved absorption and pharmacokinetic properties of the complex compared to standard silibinin formulations.
- https://www.wjgnet.com/1007-9327/full/v17/i18/2288.htm – This article discusses the clinical evidence of silymarin, including the silybin-phosphatidylcholine complex, in liver disease. It suggests that the complex improves bioavailability and shows potential clinical benefits, but emphasizes the need for more large-scale RCTs for definitive conclusions.
- https://journals.sagepub.com/doi/10.1177/1534735407301942 – This study investigates the bioavailability of silybin phytosome. The results indicate that the phytosome formulation significantly enhances the absorption of silybin, leading to higher plasma concentrations compared to standard silymarin extracts.
